We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 2,334 results
  1. Dimeric ACE2-FC Is Equivalent to Monomeric ACE2 in the Surrogate Virus Neutralization Test

    Abstract

    Angiotensin-converting enzyme 2 (ACE2) is the main cellular receptor for the dangerous sarbecoviruses SARS-CoV and SARS-CoV-2. Its...

    Denis E. Kolesov, Elizaveta A. Gaiamova, ... Ivan I. Vorobiev in Biochemistry (Moscow)
    Article 22 September 2023
  2. Spike-and-ACE2 Binding with 100 Drugs

    Durdagi (All atom 500-nano seconds molecular dynamics simulations of SARS-CoV-2 spike receptor-binding domain bound with ACE2 (Version 2) [Data set]....
    Chapter 2023
  3. Human ACE2 Ectodomain Binding with 78 Drugs

    Shaw et al. (2020) selected 5152 drug molecules from the FDA drug library and found that during 2...
    Chapter 2023
  4. ACE2 mediates tryptophan alleviation on diarrhea by repairing intestine barrier involved mTOR pathway

    The membrane-delimited receptor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), angiotensin-converting enzyme 2 (ACE2), which is...

    **ze Li, Yingli Yan, ... Wence Wang in Cellular & Molecular Biology Letters
    Article Open access 14 June 2024
  5. Determinants of species-specific utilization of ACE2 by human and animal coronaviruses

    Utilization of human ACE2 allowed several bat coronaviruses (CoVs), including the causative agent of COVID-19, to infect humans directly or via...

    Qingxing Wang, Sabrina Noettger, ... Frank Kirchhoff in Communications Biology
    Article Open access 17 October 2023
  6. Extrinsic stabilization of antiviral ACE2-Fc fusion proteins targeting SARS-CoV-2

    The angiotensin-converting enzyme 2 (ACE2) is a viral receptor used by sarbecoviruses to infect cells. Fusion proteins comprising extracellular ACE2...

    Hristo L. Svilenov, Florent Delhommel, ... Johannes Buchner in Communications Biology
    Article Open access 08 April 2023
  7. Human ACE2, Human IL6, Human IL6R, and Human nAChRs

    SARS-CoV-2, the virus causing the COVID-19 global pandemic, encodes for a trimeric spike glycoprotein that contains a receptor-binding domain (RBD)...
    Chapter 2023
  8. ACE2 inhibits proliferation of smooth muscle cell through AT1R and its downstream signaling pathway

    To investigate the effect of the angiotensin converting enzyme 2 (ACE2) on AT1R expression, ERK1/2 and STAT3 protein phosphorylation in rat vascular...

    **g**g Gong, Zhuoqiang Lu, ... Xueqing ** in Journal of Biosciences
    Article 27 July 2023
  9. Broad host tropism of ACE2-using MERS-related coronaviruses and determinants restricting viral recognition

    Recently, two Middle East respiratory syndrome coronavirus (MERS-CoV) closely related to bat merbecoviruses, NeoCoV and PDF-2180, were discovered to...

    Chengbao Ma, Chen Liu, ... Huan Yan in Cell Discovery
    Article Open access 15 June 2023
  10. ACE2-dependent and -independent SARS-CoV-2 entries dictate viral replication and inflammatory response during infection

    Excessive inflammation is the primary cause of mortality in patients with severe COVID-19, yet the underlying mechanisms remain poorly understood....

    Tianhao Duan, Changsheng **ng, ... Rong-Fu Wang in Nature Cell Biology
    Article 21 March 2024
  11. Immune evasion and ACE2 binding affinity contribute to SARS-CoV-2 evolution

    Mutations in the SARS-CoV-2 genome could confer resistance to pre-existing antibodies and/or increased transmissibility. The recently emerged Omicron...

    Wentai Ma, Haoyi Fu, ... Mingkun Li in Nature Ecology & Evolution
    Article 13 July 2023
  12. The effect of zofenopril on the cardiovascular system of spontaneously hypertensive rats treated with the ACE2 inhibitor MLN-4760

    Background

    Angiotensin converting enzyme 2 (ACE2) plays a crucial role in the infection cycle of SARS-CoV-2 responsible for formation of COVID-19...

    Sona Cacanyiova, Martina Cebova, ... Andrea Berenyiova in Biological Research
    Article Open access 25 October 2023
  13. Genetic analysis of ACE2 peptidase domain in SARS-CoV-2-positive and SARS-CoV-2-negative individuals from Pakistan

    Background

    The outbreak of coronavirus disease 2019 (COVID-19) has emerged as a serious public health emergency of global concern. Angiotensin...

    Noor Muhammad, Humaira Naeemi, ... Muhammad Usman Rashid in Molecular Biology Reports
    Article 15 March 2023
  14. Multimeric ACE2-IgM fusions as broadly active antivirals that potently neutralize SARS-CoV-2 variants

    Coronavirus infections are a world-wide threat to human health. A promising strategy to develop a broadly active antiviral is the use of fusion...

    Hristo L. Svilenov, Romina Bester, ... Johannes Buchner in Communications Biology
    Article Open access 12 November 2022
  15. A computationally designed ACE2 decoy has broad efficacy against SARS-CoV-2 omicron variants and related viruses in vitro and in vivo

    SARS-CoV-2, especially B.1.1.529/omicron and its sublineages, continues to mutate to evade monoclonal antibodies and antibodies elicited by...

    Brandon Havranek, Graeme Walker Lindsey, ... Shahidul M. Islam in Communications Biology
    Article Open access 12 May 2023
  16. Implications of SARS-CoV-2 spike protein interactions with Zn-bound form of ACE2: a computational structural study

    The COVID-19 pandemic has generated a major interest in designing inhibitors to prevent SARS-CoV-2 binding on host cells to protect against...

    Peter R. Fatouros, Urmi Roy, Shantanu Sur in BioMetals
    Article 01 February 2023
  17. Interactions of angiotensin-converting enzyme-2 (ACE2) and SARS-CoV-2 spike receptor-binding domain (RBD): a structural perspective

    Background

    Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has caused millions of infections and deaths worldwide since its discovery in...

    Subhomoi Borkotoky, Debajit Dey, Zaved Hazarika in Molecular Biology Reports
    Article 23 December 2022
  18. Association investigations between ACE1 and ACE2 polymorphisms and severity of COVID-19 disease

    Due to the unique affinity of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to the angiotensin-converting enzyme 2 (ACE2) receptor...

    Mojtaba Najafi, Mohammad Reza Mahdavi in Molecular Genetics and Genomics
    Article 18 October 2022
  19. ACE2 deficiency exacerbates obesity-related glomerulopathy through its role in regulating lipid metabolism

    Obesity-related glomerulopathy is a secondary glomerular disease and its incidence has been increased globally in parallel with the obesity epidemic....

    Yin-Yin Chen, Han Hong, ... Li-Yu He in Cell Death Discovery
    Article Open access 30 September 2022
  20. Suramin binds and inhibits infection of SARS-CoV-2 through both spike protein-heparan sulfate and ACE2 receptor interactions

    SARS-CoV-2 receptor binding domains (RBDs) interact with both the ACE2 receptor and heparan sulfate on the surface of host cells to enhance...

    Paul S. Kwon, Shirley Xu, ... Jonathan S. Dordick in Communications Biology
    Article Open access 08 April 2023
Did you find what you were looking for? Share feedback.